KRISNAMOR TORRES: Open Payments
NPI 1316611353 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 81 payments from 17 companies in 2025. Trend: 2023 $1,442 · 2024 $1,538 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $275 |
| ABBVIE INC. | 15 | $214 |
| Neurocrine BioSciences, Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 6 | $102 |
| Corium, LLC | 11 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Alkermes, Inc. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, Azstarys, COBENFY, FANAPT, Qelbree.
Industry payments across FL — which companies pay providers there.
